Standard Seven: The blood standard quality improvement cycle Philippa Kirkpatrick.

Slides:



Advertisements
Similar presentations
An Essential Tool for Optimizing Clinical Outcomes and Improving Patient Safety: The Administrative and Clinical Standards for Patient Blood Management.
Advertisements

Standard 7 – Blood and blood products
Introduction to Standard 5: Patient Identification and Procedure Matching Advice Centre Network Meeting Nicola Dunbar March 2013.
THE JOINT COMMISSION PATIENT BLOOD MANAGEMENT PERFORMANCE MEASURES
Health literacy Impact and action at a national level 26 July, 2014 Nicola Dunbar Director, Strategy and Development.
Standard 6: Clinical Handover
Medication Safety Standard 4 Part 1- Introduction Margaret Duguid, Pharmaceutical Advisor Graham Bedford, Medication Safety Program Manager Standard 4.
1 1 Chapter 1 Specimen Management Professor A. S. Alhomida Disclaimer The texts, tables and images contained in this course presentation (BCH 376) are.
1 The aim…. ‘to enable assessors to objectively assess a laboratory’s compliance with the new standards’
Governance and quality Ian Sharp November 2006 Aims of the presentation To highlight the importance of quality management and quality assurance in the.
Diagnostic Accreditation Program Accreditation Basics Helen Healey RN, BScN Director, Accreditation Services, DAP.
HAVING TROUBLE UNDERSTANDING NZS ? 2001–2008 The four previous standards were reviewed with the aim of: Reducing duplication between standards.
Standard 1: Governance for safety and quality in heath service organisations Advice Centre Network Meeting Margaret Banks Senior Program Director February.
Improving Falls Clinic client engagement in falls prevention activities National Ageing Research Institute with Royal Melbourne Hospital; Royal Park Campus,
Learnbloodtransfusion the essential guide Produced by the UK Blood Services v4 Mar
Benefits for using a standardised risk management framework to risk assess Infection Prevention and Control Sue Greig Senior Project Officer National.
Good Manufacturing Practices for Blood Establishments
STOP the WASTE! 2014/2015 Your details here. Overview Campaign – National Blood Authority What is wastage? What will you see across your hospital? Why.
Standard 5: Patient Identification and Procedure Matching Nicola Dunbar, Accrediting Agencies Surveyor Workshop, 10 July 2012.
APHA National Congress Dr Michael Smith Clinical Director 17 October 2011.
Australian Health Service Safety and Quality Accreditation Scheme Advice Centre Network Meeting Margaret Banks Senior Program Director February 2013.
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
STRATEGIC PLANNING, LEADERSHIP AND IMPLEMENTATION FOR PATIENT SAFETY Michele McKinnon Director, Safety and Quality SA HEALTH.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
Standard 7 – Blood and Blood products Philippa Kirkpatrick, Jo Cameron Accrediting Agencies Surveyor Workshop 11 July 2012.
Criteria and Standard.
Creating a service Idea. Creating a service Networking / consultation Identify the need Find funding Create a project plan Business Plan.
Risk Management and NSQHS Standards, Standard 3 – Preventing and Controlling Healthcare Associated Infections Sue Greig Senior Project Officer National.
Allied health student training Pre-placement training requirements Welcome to the video-conference. This video-conference will be recorded. Your participation.
Right Patient, Right Blood
+ Dr. Megan Rowley Consultant in Transfusion Medicine Blood Transfusion.
by Joint Commission International (JCI)
Recommended by the Sentinel Event Alert Advisory Group NATIONAL PATIENT SAFETY GOALS FY 2009.
Standard 2: Partnering with consumers Nicola Dunbar, Accrediting Agencies Surveyor Workshop, 10 July 2012.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
Module 3. Session DCST Clinical governance
The Audit Process Tahera Chaudry March Clinical audit A quality improvement process that seeks to improve patient care and outcomes through systematic.
“Crosswalking” Hospitals for a Healthy Environment (H2E) & the Joint Commission for the Accreditation of Healthcare Organizations (JCAHO) Catherine Zimmer,
Is your organisational quality system supporting you to meet the new accreditation requirements? Dr Cathy Balding
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
ACSQHC Objectives Improve safety and quality for patients using the National Safety and Quality Health Services Standards Support implementation of the.
Implementing the National Safety and Quality Health Service Standards Margaret Banks Program Director June 2, 2015 What is, and what is to come.
Patient Safety Friendly Hospital Intiative Purpose Implementation of a set of patient safety standards in hospitals Implementation of a set of patient.
How to use the EFQM Excellence Model to empower patients and staff create a latex- safe environment Karen Cunningham Health & Safety Manager Musgrave Park.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
IN THE NAME OF GOD Quality Assurance and Blood Bank S. AMINI KAFI ABAD CLINICAL AND ANATOMICAL PATHOLOGIST IRANIAN BLOOD TRANSFUSION ORGANIZATION(IBTO)
Dispensary and Administration Site Information Presentation.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
Community Pharmacy Presentation for Hospital Pharmacists July 2015.
Linking the learning to the National Standards for Safer Better Healthcare Joan Heffernan Inspector Manager Regulation – Healthcare Health Information.
ACSQHC Objectives Improve safety and quality for patients using the National Safety and Quality Health Services Standards Support implementation of the.
Medical Center Hospital is a Joint Commission Accredited Organization.
Governance & Standards What is happening internationally Triona Fortune, March 2016.
How the Clinical Effectiveness Team can help you to audit your Prescribing Practice Jude Scott Clinical Governance & Risk Management Unit Clinical Effectiveness.
WA Haemovigilance Reporting Office of the Chief Medical Officer Department of Health WA Version 1.0 July 2015.
HEALTH AND CARE STANDARDS APRIL Background Ministerial commitment 2013 – Safe Care Compassionate Care Review “Doing Well Doing Better” Standards.
A better way to care Safe and high-quality care for patients with cognitive impairment (dementia and delirium) in hospital Presented by: Mark Howland CNC.
National Accreditation Forum, Vic Health Ms Margaret Banks, A/Senior Operations Manager 25 July 2011.
NATIONAL ACCREDITATION REFORM Margaret Banks DEPARTMENT OF HEALTH, VICTORIA, 24 February 2011.
Implementation of the Australian Health Service Safety and Quality Accreditation Scheme Monday 25 July 2011.
The International Society for Quality in Health Care (ISQua) – Guidelines.
Practice Accreditation Program Update – ASO Business Skills Expo 2016.
NURS 3043 ELA 5 Transition to Practice
Governing Body QAPI 2013 Update for ASC
The Joint Commission’s National Patient Safety Goals
Critical Care Services Pharmacist Royal Manchester Children’s Hospital
Medicines Management Tips & Preparing for your CQC Inspection with Gerry Devine Practice Management Advisor.
Patient Safety Friendly Hospital Intiative
Risk Management NDS Forum June 23rd 2010.
Presentation transcript:

Standard Seven: The blood standard quality improvement cycle Philippa Kirkpatrick

Standard 7 Blood and Blood Products Standard 10 Preventing Falls and Harm from Falls Standard 1 Governance for Safety and Quality in Health Service Organisations Standard 2 Partnering with Consumers Standard 4 Medication Safety Standard 3 Healthcare Associated Infections Standard 8 Preventing and Managing Pressure Injuries Standard 9 Recognising and Responding to Clinical Deterioration in Acute Health Care Standard 5 Patient Identification and Procedure Matching Standard 6 Clinical Handover Standard 7 Blood and Blood Products The NSQHS Standards

Inherent risks Why a blood standard? Ingrained in the culture of medical practice Inappropriate transfusions Product wastage

The Blood Standard covers Use of blood and blood products The prescribing practice and clinical use of blood and blood products, and whether or not those products are prescribed and used appropriately Management of blood and blood products Handling, transport, storage (including inventory management) of blood and blood products Administration of blood and blood products The process used to deliver the product to the patient. Scope - activities

Scope BloodBiologicalMedicine Fresh blood products eg Red cells Platelets Plasma Cryoprecipitate Serum eye drops Plasma derived products eg IVIg RhD immunoglobulin Clotting factors Albumin Monoclonal antibodies Vaccines Other recombinant products Plasma derived products eg Tisseel Artiss C1-INH Fibrinogen Recombinant clotting factors Classes of products funded under National Blood Arrangements Classes of products not funded under National Blood Arrangements Haematopoietic progenitor cells Currently covered by Standard 7 Not currently covered by Standard 7

Standard 7 overview 4 criterion 23 actions One overall improvement program

Criterion One Governance and systems

Transfusion quality improvement system (Action 7.4.1) Improve quality and use of policies (7.1.3) Reduce systems risks (7.2.2) Reduce adverse event risks (7.3.1) Improve documentation (7.5.3) Reduce management risks (7.2.2) Reduce wastage (7.8.2) Improve provision of patient information (7.10.1) Reduce administration risks (7.6.2) Improve documentation of consent (7.11.1)

Oversight of the program –Review reports –Identify recurring issues –Root cause analysis of incidents –Develop or agree action plan –Evaluate effectiveness of actions Transfusion governance group (Action 7.4.1) What about in small organisations? Join with other hospitals or identify a group responsible for more than just transfusion practice (ensuring they have a clear remit to govern transfusion practice)

You should have policies, procedures and protocols that reflect best practice, and national evidence based guidelines where they are available. Your policies, procedures and protocols should cover the spectrum of: –Use of blood and blood products –Management of blood and blood products –Administration of blood and blood products Policies, procedures and protocols (Action 7.1.1)

Quality improvement cycle Plan Do Check Act Transfusion Quality Improvement System Identify what you will do - develop or identify policies, procedures or protocols Implement the policies Monitor their use AND monitor their quality Take action to improve uptake and improve their quality

Criterion Two Documenting patient information

A best possible history of blood product usage and relevant clinical and product information is documented in the patient clinical record This action builds on Action by identifying the information relevant to transfusion of blood and blood products that should be documented The patient clinical record (Action 7.5.1)

Type of product Volume of product Date and time of commencement Date and time of completion Observations Patient response including any adverse events Product identification Provision of information Patient consent or refusal Indications Special product requirements Known patient transfusion history Compatibility label or report Documentation requirements

Patient documentation case study What actions are required to demonstrate compliance with the Standard? (note that this case study is presented not to demonstrate particular actions that are required to achieve accreditation, but to demonstrate that the purpose of Standard 7 is to improve safety and quality based on an assessment of risk). Hospital OneHospital Two Has policyYes Documentation completeness audit results 50% of records are complete 95% of records are complete Documentation sample results 5% of units fate not documented <0.01% of units fate not documented

Transfusion governance group has reviewed findings and developed and implemented an action plan Outcome: the action plan is matched with the level of compliance. Case Study Hospital One Reviewed policy Implemented training of all staff Identified staff associated with non-compliance and communicated directly with them Made changes to the IT system to facilitate inclusion of all information (prompts) Increased frequency of audit on the hospital audit plan Initiated more regular spot checks of fate of product against patient records

Audit report does not have a management response or action plan They posted on the intranet a reminder to document transfusion in the patient clinical record They have not undertaken any other follow up and the next audit is scheduled for one year away Case Study Hospital One Outcome: the action plan is not matched with the level of compliance. The health service organisation needs to demonstrate additional work prior to accreditation.

They posted on the intranet a reminder to document transfusion in the patient clinical record They have not undertaken any other follow up and the next audit is scheduled for one year away Outcome: the action plan is matched with the level of compliance. Case Study Hospital Two

Recognise and respond to adverse events Document adverse events in the patient clinical record Take action to reduce the risk of adverse events as part of your transfusion quality improvement system Managing adverse events

7.6.1 Patient record Document in patient clinical record External report Report to pathology provider, or product manufacturer Local report Report in local incident system and review by Transfusion Governance Group Executive report Review of incident analysis by highest governance level State report Participate in state haemovigilance reporting National report Participate in national haemovigilance reporting Complexities of incident reporting

Criterion Three Managing blood and blood product safety

Blood must be stored and handled appropriately to prevent risk to patients. Systems should be implemented to reduce risks associated with receipt, storage, collection, and transport (Action and 7.7.2) Wastage of blood should be minimised (Action and 7.8.2) Management of blood and blood products

Many health service organisations receive blood from an outsourced pathology It remains the health service organisation’s responsibility to demonstrate compliance with the Standard Responsibility where services are outsourced You use blood provided by a contracted pathology provider Have a contract that includes standards and reporting Review reports and seek implementation of strategies to rectify problems

Criterion Four Communicating with patients and carers

Develop or identify resources to inform patients and their carers about the alternatives, risk and benefits of transfusion (Action 7.9.1) Provide this information to patients and their carers in a format that is understood and meaningful (7.10.1) Allow patients and carers to partner in decisions on their care based on the communication on the alternatives, risks and benefits of transfusion (Action 7.9.2) Communication (Actions 7.9.1, and )

Have a documented consent policy Ensure written and documented consent meets local policy Ensure the consent is actually informed – link with 7.9 and 7.10 Assess compliance with the consent policy, and take actions to increase compliance Consent (Action )

When you are developing your consent policy consider…. How long does the consent last? Who is documenting the consent? Is the consent specific to transfusion? What do you do when a patient is unable to consent?

The Standard Seven quality improvement cycle YOU CAN DO IT!

Clinical practice guidelines National Blood Authority  Patient Blood Management Guidelines Module 1: Critical Bleeding Massive Transfusion Module 2: Perioperative Module 3: Medical Module 4: Critical Care Module 5: Obstetric Module 6: Paediatric/Neonates  Guidelines on the Prophylactic Use of Rh D Immunoglobulin (anti-D) in Obstetrics  Criteria for the Clinical Use of Intravenous Immunoglobulin (second edition) NHMRC guidelines portal  Factor VIII and FIX Guidelines  Warfarin Reversal Consensus Guidelines Australian and New Zealand Society of Blood Transfusion (ANZSBT) guidelines and publications Available resources

Product information and product management  10 Tips to Help Manage you Blood Product Inventory  Managing blood and blood product inventory – Guidelines for Australian Health Providers  Australian Red Cross Blood Service Blood Component Information Circular  The Australian Red Cross Blood Service blood components and products web site  BloodSafe eLearning Australia module on Transporting Blood  ANZSBT Guidelines for the Administration of Blood Products  ANZSBT Guidelines for Pre-Transfusion Laboratory Practice  National Pathology Accreditation Advisory Council (NPAAC) Requirements for Transfusion Laboratory Practice  Australian Standard for Medical Refrigeration Equipment – For the Storage of Blood and Blood Products (AS3864)  NBA BloodNet  NBA BloodPortal  Flippin’ Blood Available resources

Adverse event recognition and reporting  See Jurisdictional programs  NBA Haemovigilance Reports  National Haemovigilance Data Dictionary  Flippin’ Blood  ANZSBT Guidelines for the Administration of Blood Products( Patient information and consent  See Jurisdictional programs  The Australian Red Cross Blood Service – Information for Patients Jurisdictional Programs  New South Wales – Blood Watch  Queensland iBlood Management Program  South Australia – BloodSafe  Victoria – Blood Matters  Western Australia Patient Blood Management Program Available resources

Thank you Images created by PresenterMedia For any queries about this presentation,